These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38170055)

  • 1. Higher perceived stress during admission is associated with shorter retention in short-term residential substance use disorder treatment.
    Ware OD; Sacco P; Cagle JG; Frey JJ; Wagner FA; Wimberly AS; Gyebi-Foster B; Diaz M; Peters K; Zemore SE
    Addict Behav Rep; 2023 Dec; 18():100502. PubMed ID: 38170055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial.
    Black DS; Amaro H
    Behav Res Ther; 2019 Sep; 120():103437. PubMed ID: 31419610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of referral source and retention among women in residential substance use disorder treatment: a prospective follow-up study.
    Rivera D; Dueker D; Amaro H
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):21. PubMed ID: 33653374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
    Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
    J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homelessness and publicly funded substance use disorder treatment in California, 2016-2019: Analysis of treatment needs, level of care placement, and outcomes.
    Padwa H; Bass B; Urada D
    J Subst Abuse Treat; 2022 Jun; 137():108711. PubMed ID: 35012791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Help Group Attendance-Associated Treatment Outcomes Among Individuals With Substance Use Disorder in Short-Term Residential Facilities.
    Mohamed R; Wen S; Bhandari R
    J Stud Alcohol Drugs; 2022 May; 83(3):383-391. PubMed ID: 35590179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of referral source and discharge outcomes among women in residential substance use disorder treatment.
    Rivera D; Dueker D; Sanchez M; Amaro H
    J Subst Abuse Treat; 2021 Jun; 125():108319. PubMed ID: 34016303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of referral source and discharge outcomes among women in residential substance use disorder treatment.
    Rivera D; Dueker D; Sanchez M; Amaro H
    J Subst Abuse Treat; 2021 Jun; 125():. PubMed ID: 33828354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.
    Stahler GJ; Mennis J
    Drug Alcohol Depend; 2020 Jul; 212():108067. PubMed ID: 32445926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the interactive effect of posttraumatic stress disorder, distress tolerance, and gender on residential substance use disorder treatment retention.
    Tull MT; Gratz KL; Coffey SF; Weiss NH; McDermott MJ
    Psychol Addict Behav; 2013 Sep; 27(3):763-73. PubMed ID: 22946858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adults With Opioid and Methamphetamine Co-use Have Lower Odds of Completing Short-Term Residential Treatment Than Other Opioid Co-use Groups: A Retrospective Health Services Study.
    Ware OD; Manuel JI; Huhn AS
    Front Psychiatry; 2021; 12():784229. PubMed ID: 34955930
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.
    Stahler GJ; Mennis J; Stein LAR; Belenko S; Rohsenow DJ; Grunwald HE; Brinkley-Rubinstein L; Martin RA
    Drug Alcohol Depend; 2022 Jul; 236():109498. PubMed ID: 35605535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment.
    Harris AH; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Rubinsky AD; Finney JW; Asch SM; Humphreys K; Trafton J
    Addict Sci Clin Pract; 2015 Oct; 10():22. PubMed ID: 26520402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US.
    Stahler GJ; Mennis J; Baron DA
    Drug Alcohol Depend; 2021 Sep; 226():108849. PubMed ID: 34198132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective.
    Baker DE; Edmonds KA; Calvert ML; Sanders SM; Bridges AJ; Rhea MA; Kosloff S
    Psychol Serv; 2020 Nov; 17(4):472-482. PubMed ID: 30816739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?
    Maturana JR; Cruz AG; Rocha-Jiménez T; Castillo-Carniglia Á
    Drug Alcohol Depend; 2023 Jul; 248():109907. PubMed ID: 37156193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.
    Mefodeva V; Carlyle M; Walter Z; Chan G; Hides L
    Addiction; 2022 Dec; 117(12):3110-3120. PubMed ID: 35851706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.